The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.
🆕Our October issue is live!
📊Articles: #ovariancancer, #breastcancer, #multiplemyeloma, #prostatecancer, #lungcancer
📉Trials: KEYLYNK-001, CHN HYPOPMRT, SYMPRO-Lung trial, OPTIMUM/MUKnine, STAMINA
🎨Cover: Cancer & the microbiome
Read here: thelancet.com/issue/S1470-...
